Protective Role of CBD Against Nicotine Pouch–Induced Seizure Aggravation and Alterations in Brain Glymphatic Biomarkers
Nicotine and Tobacco Research · 2025
DOI: 10.1093/ntr/ntaf253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nicotine and Tobacco Research, 2025. Verfasst von Bidhan Bhandari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Biology, Dental College of Georgia, Augusta University, Augusta, GA, USA. Hauptthemen laut MEDLINE: Seizures, Nicotine, Cannabidiol, Glymphatic System. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Dental College of Georgia at Augusta University, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Introduction
Nicotine pouches are rapidly increasing in popularity, yet their long-term neurological consequences remain poorly understood. Emerging evidence suggests nicotine may influence seizure susceptibility and neuroimmune signaling, while cannabidiol (CBD) has demonstrated neuroprotective and anti-inflammatory effects. This study investigated the time-dependent impact of acute versus chronic oral nicotine exposure on seizure vulnerability, neuroinflammation, and glymphatic function, and evaluated whether inhaled CBD can reverse these pathological changes.
Methods
Mice were exposed to acute or 7-day chronic nicotine pouch prior to kainic acid–induced seizures. Seizure severity was scored using the Racine scale. Neuroinflammatory markers (IL-6, HMGB1), neuronal activation markers (BDNF, c-FOS), and Aquaporin-4 (AQP4) expression were quantified via flow cytometry, immunofluorescence, and western blotting. Glymphatic function was assessed using cisterna magna injection of rhodamine dextran tracers. An ex vivo IL-6 modulation assay evaluated nicotine-induced cytokine production and CBD-mediated suppression, with or without IL-6 receptor blockade.
Results
Acute nicotine transiently reduced seizure severity, whereas chronic exposure significantly exacerbated seizures, elevated IL-6, HMGB1, BDNF, and c-FOS, and markedly downregulated AQP4. CSF tracer studies confirmed impaired glymphatic influx following chronic nicotine exposure. CBD inhalation effectively reversed seizure severity restored AQP4 expression, normalized IL-6 and HMGB1 levels, and reduced c-FOS protein expression. The IL-6R blockade assay showed that nicotine induces IL-6 production in brain-derived immune cells, while CBD suppresses this response upstream of IL-6 signaling.
Conclusions
Chronic nicotine pouch exposure promotes seizure susceptibility through converging neuroimmune and glymphatic disruptions. Inhaled CBD counteracts these effects, supporting its potential as a targeted therapeutic strategy for nicotine-associated neurological risk.
Implications
This study provides the first evidence that chronic nicotine pouch exposure disrupts glymphatic function, amplifies neuroinflammation, and increases seizure susceptibility through an IL-6–centered neuroimmune network. These findings challenge the perception of nicotine pouches as low-risk products and highlight previously unrecognized neurological vulnerabilities associated with long-term use. The ability of inhaled CBD to reverse these pathological effects identifies a promising therapeutic strategy and underscores the need for further investigation into neuroimmune–glymphatic interactions in nicotine-related brain health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oral Biology, Dental College of Georgia, Augusta University, Augusta, GA, USA.
- Center for Excellence in Research, Scholarship and Innovation (CERSI), Dental College of Georgia, Augusta, Augusta University, Augusta, GA, USA.
- The Graduate School, Augusta University, Augusta, GA, USA.
- Georgia Institute of Cannabis Research, Medicinal Cannabis of Georgia LLC, Augusta, GA, USA.
- Department of Surgery, Medical College of Georgia, Augusta University, Augusta, GA, USA.
- Piedmont Ear, Nose, Throat and Related Allergy, Atlanta, GA, USA Medical College of Georgia, Augusta University, Augusta, GA, USA.
ORCID-Profile: Bidhan Bhandari
Förderung
- Dental College of Georgia at Augusta University
- NIH HHS
- National Institutes of Health
Zitieren
APA
Bhandari, B., Naeini, S. E., Rogers, H. M., Alhashim, A. H., Yu, J. C., Seyyedi, M., Young, N., El-Marakby, A., Salles, É. L., Wang, L. P., & Baban, B. (2025). Protective Role of CBD Against Nicotine Pouch–Induced Seizure Aggravation and Alterations in Brain Glymphatic Biomarkers. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntaf253
Vancouver
Bhandari B, Naeini SE, Rogers HM, Alhashim AH, Yu JC, Seyyedi M, et al. Protective Role of CBD Against Nicotine Pouch–Induced Seizure Aggravation and Alterations in Brain Glymphatic Biomarkers. Nicotine and Tobacco Research. 2025. doi:10.1093/ntr/ntaf253
BibTeX
@article{Bhandari2025,
author = {Bhandari, Bidhan and Naeini, Sahar Emami and Rogers, Hannah M and Alhashim, Abdullah Hassan and Yu, Jack C and Seyyedi, Mohammad and Young, Nancy and El-Marakby, Ahmed and Salles, Évila Lopes and Wang, Lei P and Baban, Babak},
title = {Protective Role of CBD Against Nicotine Pouch–Induced Seizure Aggravation and Alterations in Brain Glymphatic Biomarkers},
journal = {Nicotine and Tobacco Research},
year = {2025},
doi = {10.1093/ntr/ntaf253}
}
EUVIMED